Emergent Biosolutions EBS Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $161.5M-22.8% | $209.1M-16.1% | $249.2M-8.0% | $271M+77.4% | $152.8M+44.7% | ||
| $121.6M+44.4% | $84.2M-43.7% | $149.5M+87.3% | $79.8M-60.8% | $203.7M+31.8% | ||
| $327.6M-4.6% | $343.4M-3.6% | $356.3M+5.2% | $338.6M+7.8% | $314M+0.7% | ||
| $637.6M-3.8% | $662.5M-15.8% | $786.9M+9.4% | $719.5M+1.8% | $706.8M+18.1% | ||
| $199.4M-2.9% | $205.4M-2.1% | $209.8M-2.9% | $216.1M-2.2% | $221M-18.3% | ||
| $470.4M+7.8% | $436.5M-3.6% | $452.7M-3.5% | $469M-3.3% | $485.2M-3.3% | ||
| $1.32B+0.1% | $1.32B-9.7% | $1.46B+3.1% | $1.42B-0.6% | $1.43B+2.6% | ||
| $39.5M-29.0% | $55.6M-3.1% | $57.4M-9.9% | $63.7M+9.6% | $58.1M-4.6% | ||
| $12.2M+144% | $5M-18.0% | $6.1M+24.5% | $4.9M+8.9% | $4.5M-6.3% | ||
| $148.7M+12.5% | $132.2M-3.2% | $136.5M+7.4% | $127.1M+13.6% | $111.9M-31.1% | ||
| $573.6M+0.3% | $572.1M-13.7% | $663.1M-0.7% | $667.8M+0.3% | $665.7M+0.3% | ||
| $13.3M-38.7% | $21.7M+50.7% | $14.4M+50.0% | $9.6M+43.3% | $6.7M-58.6% | ||
| 200M0.0% | 200M0.0% | 200M0.0% | 200M0.0% | 200M+199,900% | ||
| -$153M+4.3% | -$159.8M-51.9% | -$105.2M+32.7% | -$156.4M-8.3% | -$144.4M+32.0% | ||
| $523.1M+0.1% | $522.6M-10.3% | $582.5M+8.6% | $536.2M-3.0% | $552.7M+14.5% | ||
| $1.32B+0.1% | $1.32B-9.7% | $1.46B+3.1% | $1.42B-0.6% | $1.43B+2.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Emergent Biosolutions's total assets?
- Emergent Biosolutions (EBS) holds $1.3B in total assets, down 7.4% year over year.
- How much debt does Emergent Biosolutions have?
- Emergent Biosolutions carries $584.6M in total debt against $523.1M of shareholders' equity, a debt-to-equity ratio of 1.12.
- How much cash does Emergent Biosolutions have?
- Emergent Biosolutions holds $161.5M in cash and equivalents.
- Can Emergent Biosolutions cover its short-term obligations?
- Its current ratio is 4.29 — current assets exceed current liabilities.
- Where does Emergent Biosolutions's balance sheet data come from?
- Every line is extracted from Emergent Biosolutions's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
